Multiple Assemblies exist for SMTL entry 6fmj
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-Acetamidopropanethioyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl) benzyl)pyrrolidine-2-carboxamide (ligand 3); X-RAY DIFFRACTION 2.45 Å

	SMTL ID 6fmj.1 Ligands (2~{S},4~{R})-1-[(2~{S})-2-acetamidopropanethioyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 6fmj.2 Ligands (2~{S},4~{R})-1-[(2~{S})-2-acetamidopropanethioyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 6fmj.3 Ligands (2~{S},4~{R})-1-[(2~{S})-2-acetamidopropanethioyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 6fmj.4 Ligands (2~{S},4~{R})-1-[(2~{S})-2-acetamidopropanethioyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer